Kathryn Boor - Dec 5, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Director
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Kathryn Boor
Stock symbol
SRPT
Transactions as of
Dec 5, 2024
Transactions value $
-$205,400
Form type
4
Date filed
12/6/2024, 08:00 PM
Previous filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Sale -$205K -1.64K -21.77% $125.55 5.88K Dec 5, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards.